| Single-nucleotide polymorphisms in the IL2RA gene are associated with age at diagnosis in late-onset Finnish type 1 diabetes subjects MW Klinker, JJ Schiller, VL Magnuson, T Wang, J Basken, K Veth, ... Immunogenetics 62, 101-107, 2010 | 38 | 2010 |
| Identification of a serum-induced transcriptional signature associated with type 1 diabetes in the BioBreeding rat M Kaldunski, S Jia, R Geoffrey, J Basken, S Prosser, S Kansra, JP Mordes, ... Diabetes 59 (10), 2375-2385, 2010 | 34 | 2010 |
| Specificity of Phosphorylation Responses to Mitogen Activated Protein (MAP) Kinase Pathway Inhibitors in Melanoma Cells. ANG Basken J, Stuart SA, Kavran AJ, Lee T, Ebmeier CC, Old WM Molecular & Cellular Proteomics 17 (4), 550-564, 2018 | 30 | 2018 |
| Genetic association of HLA DQB1 with CD4+ CD25+ high T-cell apoptosis in type 1 diabetes S Glisic, M Klinker, J Waukau, P Jailwala, S Jana, J Basken, T Wang, ... Genes & Immunity 10 (4), 334-340, 2009 | 24 | 2009 |
| Intermittent treatment of BRAFV600E melanoma cells delays resistance by adaptive resensitization to drug rechallenge AJ Kavran, SA Stuart, KR Hayashi, JM Basken, BJ Brandhuber, NG Ahn Proceedings of the National Academy of Sciences 119 (12), e2113535119, 2022 | 20 | 2022 |
| Predictive biomarker evaluation and molecular differentiation for imipridones ONC201 and ONC206. S Morrow, K Nath, Y Zhang, MJ Garnett, U McDermott, CH Benes, ... Cancer Research 81 (13), 2021 | 1 | 2021 |
| Genome-wide binding analysis of 195 DNA binding proteins reveals “reservoir” promoters and human specific SVA-repeat family regulation MJ Smallegan, S Shehata, SF Spradlin, A Swearingen, G Wheeler, A Das, ... Plos one 16 (6), e0237055, 2021 | 1 | 2021 |
| DDRE-33. MOLECULAR DIFFERENTIATION OF IMIPRIDONES ONC201 AND ONC206 V Prabhu, C Cuoco, J Jung, S Morrow, AR Kawakibi, B Willette, M Day, ... Neuro-Oncology 22 (Supplement_2), ii68-ii68, 2020 | 1 | 2020 |
| Genome-wide binding analysis of 195 DNA Binding Proteins reveals “reservoir” promoters and human specific SVA-repeat family regulation S Shehata, S Spradlin, A Swearingen, G Wheeler, A Das, G Corbet, ... Biorxiv, 2020.07. 21.213603, 2020 | 1 | 2020 |
| Method of screening a therapy for induction of ferroptosis T Read, J Azofeifa, LAI Maria, J Basken US Patent App. 18/150,753, 2023 | | 2023 |
| Methods of functional linkage of chromosomal positions T Read, J Azofeifa, LAI Maria, J Basken US Patent App. 18/150,750, 2023 | | 2023 |
| Method for identifing a marker for a biological interaction T Read, J Azofeifa, LAI Maria, J Basken US Patent App. 18/150,752, 2023 | | 2023 |
| New therapeutic targets of ER positive breast cancer are revealed through nascent RNA transcription time series J Azofeifa, J Basken, M Lai, R Langendorf, L Norris, T Read, ... Cancer Research 80 (16_Supplement), 5854-5854, 2020 | | 2020 |
| Co-treatment of MEKi and BRD4 inhibitors lead to synergistic repression of MYC-associated enhancer RNAs J Azofeifa, J Basken, M Lai, R Langendorf, L Norris, T Read, ... Cancer Research 80 (16_Supplement), 4689-4689, 2020 | | 2020 |
| Enhancer RNA cell line database reveals new associations between TF activity and cancer subtype J Azofeifa, J Basken, M Lai, R Langendorf, L Norris, T Read, ... Cancer Research 80 (16_Supplement), 1272-1272, 2020 | | 2020 |
| IND-enabling characterization of ONC206 as the next bitopic antagonist for oncology VV Prabhu, S Morrow, CA Cuoco, AR Kawakibi, J Jung, N Madhukar, ... Cancer Research 80 (16_Supplement), 5688-5688, 2020 | | 2020 |
| TWO DAY TIME SERIES OF NASCENT RNA LEVELS EXPLAINS TF REGULATION OF THE MAPK PATHWAY RE Langendorf, A Biosciences, JG Azofeifa, JM Basken, MB Lai | | 2020 |
| Abstract LB-B15: New causal drivers of estrogen signaling revealed by dense time series of nascent RNA transcription R Langendorf, J Basken, M Lai, J Azofeifa Molecular Cancer Therapeutics 18 (12_Supplement), LB-B15-LB-B15, 2019 | | 2019 |
| ACUTE GENE EXPRESSION ANALYSIS OF OVINE VAGINAL TISSUE POST-TREATMENT WITH A CRYOGEN-COOLED MONOPOLAR RADIOFREQUENCY DEVICE S Lathers, J Azofeifa, J Basken, S Bell INTERNATIONAL UROGYNECOLOGY JOURNAL 30, S294-S295, 2019 | | 2019 |
| Specificity of Molecular Responses to Erk1/2 and Mkk1/2 Inhibitors in Melanoma Cells JM Basken | | 2017 |
